Peter Sieger

This inventor holds 40 USPTO granted patents and 15 published patent applications, plus 14 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Polymorphs. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Kg, Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2003-2024.

USPTO Granted Patents = 40 (Patent Applications = 15)

% Patents Active = 92.5

CIPO Patents = 14 (Patent Applications = 1)

EPO Patents = 16 (Patent Applications = 25)

Average Co-Inventor Count = 3.4

ph-index = 14

Forward Citations = 547(Granted Patents)

Location History:

Mittlebiberach, DE (2011 - 2012)
Mittelbiberach, DE (2003 - 2024)

Company Filing History:

32 out of 1,560

Boehringer Ingelheim International Gmbh

patents

4 out of 149

Boehringer Ingelheim Pharma Kg

patents

3 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

Polymorphs

Pharmaceuticals

Xanthine Compounds

Beta Agonists

Salt Forms

Medicaments

Crystalline Forms

Hydrates

Enantiomers

Anticholinergic

Preparation Processes

Dihydropteridione

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11919903 - Polymorphs (2024-03-05),

2. 11447474 - Solid forms of a GlyT1 inhibitor (2022-09-20),

3. 11084819 - Polymorphs (2021-08-10),

4. 10301313 - Polymorphs (2019-05-28),

5. 9815837 - Polymorphs (2017-11-14),

6. 9493462 - Polymorphs (2016-11-15),

7. 9309228 - Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof (2016-04-12),

8. 9266888 - Polymorphs (2016-02-23),

9. 9212183 - Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine (2015-12-15),

10. 8906931 - 9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof (2014-12-09),

11. 8865729 - Salt forms of a xanthine compound (2014-10-21),

12. 8853225 - 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof (2014-10-07),

13. 8686148 - Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof (2014-04-01),

14. 8664222 - Specific salt, anhydrous and crystalline form of a dihydropteridione derivative (2014-03-04),

15. 8637530 - 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals (2014-01-28),

Title: The Innovative Journey of Peter Sieger

Introduction:

Peter Sieger, a visionary inventor hailing from Mittelbiberach, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Peter Sieger's latest patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and security.

Career Highlights:

With a career spanning over two decades, Peter Sieger has established himself as a leading figure in the field of technology, holding numerous patents in areas such as renewable energy, IoT devices, and advanced robotics.

Collaborations:

Throughout his career, Peter Sieger has collaborated with top research institutions and leading tech companies to bring his innovative ideas to life. His partnerships have led to the development of cutting-edge products that have reshaped industries.

Conclusion:

Peter Sieger's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a pioneering inventor in the global tech landscape. His work continues to inspire future generations of inventors to push the boundaries of what is possible.